Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma.
Gentian DenasGiacomo ZoppellaroSeena Padayattil JoseEmilia AntonucciFrancesco MarongiuDaniela PoliSophie TestaArmando TripodiGualtiero PalaretiVittorio PengoPublished in: Cardiovascular therapeutics (2017)
We found an elevated risk of major bleeding and intracranial hemorrhage in NVAF individuals treated with warfarin with 1 NGR risk factor for stroke. These data call for caution when treating with warfarin these individuals.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- direct oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- heart failure
- risk factors
- percutaneous coronary intervention
- electronic health record
- venous thromboembolism
- combination therapy
- machine learning
- left ventricular
- drug induced
- replacement therapy
- blood brain barrier
- acute coronary syndrome
- optical coherence tomography
- smoking cessation